Within 5 years, the world could widely accept that we are within striking distance of a post-aging world. This could be with the achievement of mice that would normally die at the age of three getting life extension at the age of two and living beyond 5 years. It might be after that with the similar treatments to reverse aging in dogs. It could be with the first age reversal treatments in humans that make people look significantly younger but also restore muscle and other body functions.

Investors would then accelerate any funding needed to complete several very promising anti-aging treatments which are currently being worked upon.

One of the many George Church companies is Rejuvenate Bio. This is a stealth company that has been running tests to reverse aging in dogs.

They are performing aging reversal trials on dog this year and next year. Human trials would be in 2019-2022 and about 2025 before they are done.

They have a pipeline of more than 60 different gene therapies, which they tested on old mice, alone and in combinations. The Harvard group now plans to publish a scientific report on a technique that extends rodents' lives by modifying two genes to act on four major diseases of aging: heart and kidney failure, obesity, and diabetes. According to Church, the results are pretty eye-popping.

How soon will we see results of medical regeneration revolution?

Michael D. West, Ph.D., CEO of AgeX Therapeutics, discusses the medical regeneration revolution by looking back at how advances in recombinant DNA and monoclonal antibodies helped usher in new products that improved the quality of human life after decades of research. Dr. West also addresses pluripotent stem cells and how unlocking their potential will spur the next big medical revolution: regenerative medicine.

West indicates that the technologies that make up regenerative medicine have already been under development for 20 years. The technologies are already maturing.